|
시장보고서
상품코드
2054323
수면 보조제 시장 : 제품 유형별, 수면 장애별, 지역별Sleep Aids Market, By Product Type, By Sleep Disorder, By Geography |
||||||
수면 보조제 시장은 2026년에 904억 5,000만 달러로 추정되고 있으며, 2033년까지 1,550억 2,000만 달러에 이를 전망입니다. 2026-2033년 CAGR 8.0%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모 : 2026년 | 904억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR : 2026-2033년 | 8.00% | 시장 규모 예측 : 2033년 | 1,550억 2,000만 달러 |
세계의 수면 보조제 시장은 수면장애 유병률 증가로 인해 최근 몇 년간 꾸준한 성장을 거듭하고 있습니다. 스트레스 수준 증가, 생활 방식의 변화, 그리고 고령화의 진행이 불면증 및 기타 수면장애를 부추기는 주요 요인으로 대두되고 있습니다. 또한, 수면 부족이 건강과 생산성에 미치는 악영향에 대한 인식이 높아짐에 따라, 치료를 받는 사람들이 늘어나고 있습니다. 사람들이 충분한 휴식을 취할 수 있도록, 시중에는 다양한 수면제와 기기가 넘쳐나고 있습니다. 건강에 대한 관심이 높아짐에 따라, 허브나 건강기능식품 등 보다 자연 친화적인 제품들도 수면 개선을 위해 인기를 끌고 있습니다. 수면 보조 시장은 혁신으로 이어지는 지속적인 연구 개발과 신흥국 수요 증가를 배경으로, 향후 몇 년간 높은 성장률을 유지할 것으로 예측됩니다.
시장 역학
세계의 수면 보조제 시장은 주로 식생활의 변화, 바쁜 생활 방식, 스트레스 수준 증가로 인한 수면장애 유병률 상승에 힘입어 성장하고 있습니다. 수면 부족은 비만, 심장병, 우울증 등 수많은 건강 문제와 관련이 있으며, 이로 인해 수면 보조제 사용이 증가하고 있습니다. 수면장애에 걸리기 쉬운 고령 인구 증가 또한 업계 관계자들에게 큰 잠재 시장으로 떠오르고 있습니다. 그러나 처방 수면제에 따른 부작용과 위험은 큰 과제로 대두되고 있습니다. 또한, 많은 국가에서 대체 요법을 선호하는 경향이 있어 시장의 수익 성장을 어느 정도 저해하고 있습니다. 한편, 웨어러블 기기와 모바일 앱을 활용한 수면 기술의 혁신 속도는 새로운 기회를 가져오고 있습니다. 불면증의 영향에 대한 인식이 높아지고, 신흥국의 의료 인프라가 개선됨에 따라 향후 업계의 성장이 더욱 가속화될 것입니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 수면 보조제 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 조사에서 다루고 있는 주요 기업은 Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca입니다.
- 본 보고서의 분석 결과는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있도록 돕습니다.
- 세계의 수면 보조제 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 수면 보조제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 수면 보조제 시장 : 제품 유형별(2021-2033년)
제5장 세계의 수면 보조제 시장 : 수면 장애별(2021-2033년)
제6장 세계의 수면 보조제 시장 : 지역별(2021-2033년)
제7장 경쟁 구도
제8장 애널리스트의 견해
제9장 참고 문헌 및 조사 방법
AJY 26.06.17Sleep Aids Market is estimated to be valued at USD 90.45 Bn in 2026 and is expected to reach USD 155.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 90.45 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 155.02 Bn |
The global sleep aids market has been witnessing steady growth in the last few years owing to the increasing prevalence of sleep disorders. Rising stress levels, changing lifestyles, and growing aging population have emerged as major factors fueling insomnia and other sleep disorders. Moreover, growing awareness about the ill-effects of sleep deprivation on health and productivity are prompting a greater number of people to seek treatment. Various sleep medications and devices have flooded the market to help people get adequate rest. With growing health consciousness, more natural products like herbs and supplements are also gaining popularity for sleep promotion. The sleep aids market is expected to further grow at a notable rate in the coming years on the back of ongoing research and development leading to innovations as well as increasing demand from emerging countries.
Market Dynamics
The global sleep aids market is driven by the rising prevalence of sleep disorders mainly due to changing dietary patterns, busy lifestyles, and increasing stress levels. Sleep deprivation is linked to numerous health issues like obesity, heart diseases, and depression which has boosted the adoption of sleep aids. The growing geriatric population which is more prone to sleep disorders also presents a large addressable market for industry players. However, side effects and risks associated with prescription sleep drugs pose a major challenge. Also, preference for alternative therapies in many countries hamper the market revenue growth to some extent. On the other hand, pace of innovation in sleep technology involving wearable devices and mobile apps offer new opportunities. Growing awareness about the consequences of insomnia and improving healthcare infrastructure in emerging nations will further support industry expansion going forward.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global sleep aids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global sleep aids market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep aids market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Medications
- Sleep Apnea Devices
- Mattresses and Pillows
- Others
- Sleep Disorder Insights (Revenue, USD Bn, 2021 - 2033)
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome
- Night Terrors
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- GSK plc.
- Sommetrics, Inc.
- Cadwell Industries, Inc.
- SleepMed, Inc.
- Natus Medical Incorporated
- Therapix Biosciences Ltd
- Compumedics Limited
- Eisai Co., Ltd.
- Tris Pharma, Inc.
- Novartis AG
- Idorsia Pharmaceuticals Ltd.
- ResMed
- AstraZeneca
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sleep Disorder
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Sleep Aids Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sleep Apnea Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mattresses and Pillows
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Sleep Aids Market, By Sleep Disorder 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Insomnia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sleep Apnea
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Restless Legs Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Night Terrors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Sleep Aids Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sommetrics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cadwell Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SleepMed, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Natus Medical Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Therapix Biosciences Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Compumedics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tris Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Idorsia Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ResMed
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
8. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
